Financial Performance Highlights

Income Statement (₹ Lacs):

  • Revenue from Operations: FY26 ₹32.28 vs FY25 ₹89.81 (64% decline)
  • Other Income: FY26 ₹(-15.09) vs FY25 ₹52.62
  • Total Revenue: FY26 ₹17.19 vs FY25 ₹142.44 (88% decline)
  • Employee Benefit Expenses: FY26 ₹(-1.46) vs FY25 ₹36.64
  • Finance Costs: FY26 ₹0.04 vs FY25 ₹0.16
  • Depreciation: FY26 ₹(-0.36) vs FY25 ₹5.45
  • Provision for loans: FY26 ₹22.91 vs FY25 ₹4.53
  • Other Expenses: FY26 ₹30.07 vs FY25 ₹30.97
  • Total Expenses: FY26 ₹51.20 vs FY25 ₹77.74
  • Profit/(Loss) Before Tax: FY26 ₹(-34.02) vs FY25 ₹64.70
  • Tax Expenses: FY26 ₹(-9.15) [Current Tax ₹(-9.25) + Deferred Tax ₹0.10]
  • Net Profit/(Loss): FY26 ₹(-24.87) vs FY25 ₹51.03

Quarterly Performance (₹ Lacs):

  • Q4 FY26: Revenue ₹17.19, Net Loss ₹24.87
  • Q3 FY26: Revenue ₹95.62, Net Profit ₹22.75
  • Q2 FY26: Revenue ₹29.14, Net Profit ₹0.35
  • Q1 FY26: Revenue ₹179.36, Net Profit ₹6.67

Earnings Per Share (₹):

  • Basic EPS: FY26 ₹(-0.93) vs FY25 ₹1.90
  • Diluted EPS: FY26 ₹(-0.93) vs FY25 ₹1.90

Capital Structure

  • Paid-up Share Capital: ₹268.74 lacs (unchanged from previous periods)
  • Total Equity: ₹603.06 lacs
  • Total Assets: ₹623.29 lacs
  • Total Liabilities: ₹20.23 lacs

Cash Flow Statement (₹ Lacs)

  • Net cash flows from operating activities: ₹14.10
  • Net cash flows from investing activities: ₹(-0.01)
  • Net cash flows from financing activities: ₹(-84.19)
  • Net decrease in cash and cash equivalents: ₹(-70.10)
  • Cash and cash equivalents at beginning: ₹24.69
  • Cash and cash equivalents at end: ₹(-45.41)

Key Balance Sheet Items (₹ Lacs)

  • Financial Assets: ₹593.77 (including Loans ₹520.36, Investments ₹27.64, Cash ₹45.76)
  • Non-Financial Assets: ₹29.52
  • Equity Share Capital: ₹426.10
  • Other Equity: ₹176.96
  • Financial Liabilities: ₹10.18
  • Non-Financial Liabilities: ₹10.05

Emphasis of Matter

The auditor highlighted that the company's shares were suspended from trading at BSE but were relisted on November 27, 2025, following revocation approval on November 19, 2025.